Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
225,970,109
Total 13F shares
204,604,844
Share change
+4,086,205
Total reported value
$79,498,363,022
Put/Call ratio
71%
Price per share
$388.96
Number of holders
1,568
Value change
+$1,439,627,570
Number of buys
713
Number of sells
790

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
9.8%
22,152,108
$9,635,280,896 31 Mar 2025
13F
BlackRock, Inc.
13F 13D/G
Company
7.8%
from 13D/G
21,311,015
$9,269,439,181 31 Mar 2025
STATE STREET CORP
13F
Company
4.7%
10,647,703
$4,631,324,897 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4%
9,142,563
$3,976,650,000 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.6%
5,794,794
$2,520,503,599 31 Mar 2025
13F
Capital International Investors
13F
Company
2.5%
5,555,887
$2,416,371,100 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
5,166,715
$2,245,109,846 31 Mar 2025
13F
Sanders Capital, LLC
13F
Company
2.1%
4,672,768
$2,032,467,169 31 Mar 2025
13F
Artisan Partners Limited Partnership
13F
Company
1.5%
3,350,780
$1,457,455,269 31 Mar 2025
13F
First Eagle Investment Management, LLC
13F
Company
1.4%
3,241,361
$1,409,862,551 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.3%
2,973,109
$1,293,184,547 31 Mar 2025
13F
Orbis Allan Gray Ltd
13F
Company
1.3%
2,849,173
$1,239,276,288 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
1.2%
2,676,203
$1,164,041,256 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.1%
2,442,357
$1,062,327,601 31 Mar 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
1.1%
2,426,828
$1,055,573,106 31 Mar 2025
13F
BAILLIE GIFFORD & CO
13F
Company
1%
2,303,038
$1,001,729,409 31 Mar 2025
13F
HARRIS ASSOCIATES L P
13F
Company
1%
2,280,159
$991,777,969 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.98%
2,204,720
$958,964,997 31 Mar 2025
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
0.96%
2,158,991
$939,074,528 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.94%
2,116,289
$920,500,819 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.86%
1,943,616
$845,393,833 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.84%
1,891,868
$822,886,905 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.8%
1,816,128
$789,942,852 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.79%
1,795,549
$780,991,987 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.79%
1,794,952
$780,686,130 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.79%
1,782,653
$775,382,749 31 Mar 2025
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.79%
1,777,584
$773,177,937 31 Mar 2025
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.7%
1,589,089
$691,190,151 31 Mar 2025
13F
EAGLE CAPITAL MANAGEMENT LLC
13F
Company
0.7%
1,585,348
$689,562,966 31 Mar 2025
13F
Brave Warrior Advisors, LLC
13F
Company
0.7%
1,577,570
$686,179,847 31 Mar 2025
13F
FMR LLC
13F
Company
0.68%
1,544,587
$671,834,014 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.63%
1,424,984
$619,811,359 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.62%
1,405,073
$611,150,662 31 Mar 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.61%
1,388,595
$603,983,282 31 Mar 2025
13F
EdgePoint Investment Group Inc.
13F
Company
0.57%
1,294,560
$563,081,818 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.56%
1,274,403
$554,314,527 31 Mar 2025
13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC
13F
Company
0.56%
1,270,594
$552,657,566 31 Mar 2025
13F
Amundi
13F
Individual
0.48%
1,084,157
$490,787,033 31 Mar 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.5%
1,136,041
$489,519,892 31 Mar 2025
13F
Ruane, Cunniff & Goldfarb L.P.
13F
Company
0.5%
1,122,920
$488,425,283 31 Mar 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.48%
1,086,083
$469,187,856 31 Mar 2025
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.47%
1,073,173
$468,375,624 31 Mar 2025
13F
Newport Trust Company, LLC
13F
Company
0.47%
1,067,068
$464,131,897 31 Mar 2025
13F
Veritas Asset Management LLP
13F
Company
0.42%
952,903
$414,474,689 31 Mar 2025
13F
UBS Group AG
13F
Company
0.41%
935,406
$406,864,194 31 Mar 2025
13F
Boston Partners
13F
Company
0.38%
856,737
$372,038,670 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.38%
854,410
$371,634,174 31 Mar 2025
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.38%
849,454
$369,478,512 31 Mar 2025
13F
1832 Asset Management L.P.
13F
Company
0.36%
815,505
$354,712,055 31 Mar 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.36%
807,209
$351,103,627 31 Mar 2025
13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2025

As of 30 Jun 2025, Elevance Health, Inc. - Common Stock (ELV) was held by 1,568 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 204,604,844 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Artisan Partners Limited Partnership, and First Eagle Investment Management, LLC. This page lists 1,577 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
1,638
Q2 2025 holders
1,568
Holder diff
-70
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.